Management of recurrence after surgery for hepatocellular carcinoma (rHCC) is still a debate. The aim was to compare the Survival after Recurrence (SAR) of curative (surgery or thermoablation) versus palliative (TACE or Sorafenib) treatments for patients with rHCC.
Curative versus palliative treatments for recurrent hepatocellular carcinoma: a multicentric weighted comparison / Famularo, Simone; Donadon, Matteo; Cipriani, Federica; Bernasconi, Davide P; Labarba, Giuliano; Dominioni, Tommaso; Iaria, Maurizio; Molfino, Sarah; Conci, Simone; Ferrari, Cecilia; Garatti, Marco; Delvecchio, Antonella; Troci, Albert; Patauner, Stefan; Frassani, Silvia; Cosimelli, Maurizio; Zanus, Giacomo; Giuliante, Felice; Jovine, Elio; Valsecchi, Maria G; Grazi, Gianluca; Antonucci, Adelmo; Frena, Antonio; Crespi, Michele; Memeo, Riccardo; Zimmitti, Giuseppe; Griseri, Guido; Ruzzenente, Andrea; Baiocchi, Gianluca; Dallavalle, Raffaele; Maestri, Marcello; Ercolani, Giorgio; Aldrighetti, Luca; Torzilli, Guido; Romano, Fabrizio. - In: HPB. - ISSN 1365-182X. - 23:6(2021), pp. 889-898. [10.1016/j.hpb.2020.10.007]
Curative versus palliative treatments for recurrent hepatocellular carcinoma: a multicentric weighted comparison
Cipriani, Federica;Aldrighetti, Luca;
2021-01-01
Abstract
Management of recurrence after surgery for hepatocellular carcinoma (rHCC) is still a debate. The aim was to compare the Survival after Recurrence (SAR) of curative (surgery or thermoablation) versus palliative (TACE or Sorafenib) treatments for patients with rHCC.| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S1365182X20311953-main.pdf
solo gestori archivio
Tipologia:
PDF editoriale (versione pubblicata dall'editore)
Licenza:
Copyright dell'editore
Dimensione
863.35 kB
Formato
Adobe PDF
|
863.35 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
